APX 0.00% 46.0¢ appen limited

<p><strong>Appen is buying Figure Eight technologies for $250...

  1. 1,744 Posts.
    lightbulb Created with Sketch. 608
    <p><strong>Appen is buying Figure Eight technologies for $250 million</strong>, plus an earn-out consideration of about $86 million to $114 million (capped at $178 million). <strong>Figure Eight, previously called Crowdflower</strong>,
    is a San Francisco based company with about 107 employees and 200
    customers that sells machine learning software to "transform
    unstructured text, image, audio, and video data into customised high
    quality artificial intelligence training data". </p><p>To pay for the purchase Appen is doing a <strong>$285 million placement at $21.50 per share, a 12 per cent discount</strong>. It has also struck a new syndicated banking loan for $125 million, on top of an existing $60 million debt facility. </p><p data-gtm-vis-recent-on-screen-6236702_632="1552258514968" data-gtm-vis-first-on-screen-6236702_632="1552258514968" data-gtm-vis-total-visible-time-6236702_632="4000" data-gtm-vis-has-fired-6236702_632="1">"The
    union of Appen and Figure Eight creates a unique, exciting and powerful
    opportunity for our customers," Appen chief executive <strong>Mark Brayan</strong> said. </p><p>"We
    now have the best of both worlds: Appen's highly efficient crowd
    management platform and scalable, skilful multi-lingual crowd, combine
    with Figure Eight's innovative customer facing SaaS platform...we expect
    to meet and exceed our customers' scale, speed and quality
    requirements". </p>
 
watchlist Created with Sketch. Add APX (ASX) to my watchlist
(20min delay)
Last
46.0¢
Change
0.000(0.00%)
Mkt cap ! $102.5M
Open High Low Value Volume
46.5¢ 47.0¢ 46.0¢ $245.6K 528.2K

Buyers (Bids)

No. Vol. Price($)
13 210127 46.0¢
 

Sellers (Offers)

Price($) Vol. No.
46.5¢ 52030 2
View Market Depth
Last trade - 16.10pm 23/07/2024 (20 minute delay) ?
APX (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.